OMAH vs SCHD: Which Is the Better Pick in 2026?

Overview

OMAH is an actively managed options income ETF launched in March 2025 that targets a 15% annual distribution by holding Berkshire Hathaway Class B shares plus Berkshire's 20 largest U.S. stock holdings, with a covered-call overlay executed monthly. SCHD is a passively managed dividend equity ETF tracking the Dow Jones U.S. Dividend 100 Index, holding 100 large-cap U.S. stocks with strong dividend-payment histories, and has been operating since 2011. The key distinction is their distribution strategy: OMAH pursues outsized yield through active options selling on a concentrated equity basket, while SCHD delivers modest yield from fundamental dividend growth with broad diversification.

How they differ

OMAH targets a 15.05% distribution rate through options income, while SCHD yields 2.93% from traditional dividend growth—a fundamental gap in income generation philosophy. OMAH's strategy concentrates exposure to Berkshire Hathaway and its disclosed stock holdings, then layers a covered-call overlay for monthly cash; SCHD uses index replication to hold 100 stocks selected for consistent dividend payers. OMAH carries a 0.98% expense ratio reflecting active management and options execution, versus SCHD's 0.06% passive-tracking cost. OMAH launched just weeks before this snapshot and holds $1.02B in assets; SCHD has operated for over a decade and manages $106B, indicating vastly different levels of track record visibility and capital establishment. OMAH's beta of 0.33 suggests its options overlay dampens price volatility, while SCHD's 0.56 beta indicates closer alignment with large-cap equity moves.

Who each is best for

OMAH: Fits investors who prioritize monthly cash flow and accept significant execution risk and NAV exposure in exchange for a distribution target substantially above traditional dividend yields, and who want concentrated exposure to high-conviction, actively selected holdings.

SCHD: Fits investors who seek broad, passively managed large-cap dividend exposure with minimal expense drag, are comfortable with quarterly distributions and modest yields typical of fundamental dividend-growth strategies, and value the transparency and stability of index-tracking mechanics.

Key risks to know

• NAV erosion at 15%+ yield: OMAH's 15.05% distribution rate implies aggressive return-of-capital treatment and synthetic income generation. If option premiums, Berkshire dividends, and stock appreciation fail to sustain this payout, NAV will decline materially over time.

• Concentrated equity exposure: OMAH holds only 21 positions (Berkshire plus 20 stocks from its portfolio). Adverse moves in Berkshire or its largest holdings create outsized drawdown risk compared to SCHD's 100-stock diversification.

• Covered-call execution risk: OMAH's monthly options overlay can cap upside if call strikes are struck in-the-money during rallies; this drag accumulates when the underlying Berkshire portfolio experiences strong appreciation.

• Minimal operating history: OMAH's inception date of March 2025 means no meaningful historical cycle data. Performance during market stress, dividend cuts, or options volatility remains untested.

• Dividend sustainability in SCHD: While SCHD's index methodology selects dividend-paying stocks, economic recession or widespread earnings pressure could force cuts by constituents, reducing distributions below the 2.93% current rate.

Bottom line

OMAH and SCHD serve opposite investor needs: OMAH pursues maximum current income through leverage and options selling on a concentrated portfolio, accepting NAV risk and minimal track record; SCHD offers cost-efficient exposure to dividend-growth fundamentals with broad diversification and a 14-year operating history. If you prioritize stable income aligned with stock performance and low costs, SCHD's simplicity and scale dominate. If you accept concentration and synthetic-income mechanics in pursuit of 15% monthly distributions, OMAH's active options strategy may fit—but its newness means past performance data cannot inform future results.